These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1702581

  • 1. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G, Herbrecht R, Tilly H, Berger F, Brousse N, Gisselbrecht C, Coiffier B.
    Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].
    Salles G, Herbrecht R, Brice P, Sebbań C, Tilly H, Lederlin P, Berger F, Coiffier B.
    Ann Gastroenterol Hepatol (Paris); 1992 Jan; 28(4):205-8. PubMed ID: 1280028
    [Abstract] [Full Text] [Related]

  • 3. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E.
    Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
    Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N.
    J Clin Oncol; 1989 Aug; 7(8):1018-26. PubMed ID: 2474057
    [Abstract] [Full Text] [Related]

  • 6. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).
    Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J.
    Ann Oncol; 1990 Aug; 1(1):45-50. PubMed ID: 1706610
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
    Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F, Coiffier B.
    Ann Oncol; 1993 Sep; 4(8):651-6. PubMed ID: 7694634
    [Abstract] [Full Text] [Related]

  • 8. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma.
    Binn M, Ruskoné-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, Lavergne A, Guettier C, Delchier JC.
    Ann Oncol; 2003 Dec; 14(12):1751-7. PubMed ID: 14630680
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P, Cazals D, Mounier N, Verola O, Neidhart-Berard AM, Remenieras L, Deconinck E, Doyen C, Hamelsand J, Molina T, Moulonguet I, Gisselbrecht C.
    Leukemia; 1998 Feb; 12(2):213-9. PubMed ID: 9519784
    [Abstract] [Full Text] [Related]

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 12. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Diviné M, Lepage E, Brière J, Pautier P, Dupriez B, Lederlin P, Mineur P, Tilly H, Blanc M, Audhuy B, Herbrecht R, Coiffier B, Reyes F.
    J Clin Oncol; 1996 Jan; 14(1):240-8. PubMed ID: 8558204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
    Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F.
    J Clin Oncol; 1997 Mar; 15(3):1131-7. PubMed ID: 9060555
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
    Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J.
    J Clin Oncol; 1992 Oct; 10(10):1615-23. PubMed ID: 1383435
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.
    Dumontet C, Bastion Y, Felman P, Ffrench M, Blanc M, Peaud PY, Coiffier B.
    Ann Oncol; 1992 Sep; 3(8):639-44. PubMed ID: 1280459
    [Abstract] [Full Text] [Related]

  • 18. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
    Coiffier B, Bryon PA, Berger F, Archimbaud E, Ffrench M, Extra JM, Guyotat D, Fiere D, Gentilhomme O, Magaud JP.
    J Clin Oncol; 1986 Feb; 4(2):147-53. PubMed ID: 2418166
    [Abstract] [Full Text] [Related]

  • 19. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
    Linassier C, Desablens B, Lefrancq T, Le Prise PY, Harousseau JL, Jacob C, Gandhour C, Haillot O, Lucas V, Leloup R, Escoffre M, Colombat P, Tabuteau S, GOELAMS Study Group.
    Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394
    [Abstract] [Full Text] [Related]

  • 20. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
    Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, Bosly A, Morel P, Nouvel C, Tilly H, Lederlin P, Sebban C, Brière J, Gaulard P, Reyes F.
    J Clin Oncol; 2000 Aug; 18(16):3025-30. PubMed ID: 10944137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.